Best MedTech Oncology Business 2024 – Canada
Montreal / April 19, 2024 - NexPlasmaGen is honored to announce that it has won GHP magazine's Best MedTech Oncology Business - Canada...
19 April, 2024
/ 0 Comments
Masonry
Second US patent granted
Montreal / April 05, 2024 - NexPlasmaGen is pleased to announce that on February 6, 2024, the 2nd U.S. patent (US 11895763B2) was...
05 April, 2024
/ 0 Comments
NexPlasmaGen’s new funding for R&D and commercialization
Montreal / October 06, 2023 - NexPlasmaGen received a financial support of $219,500 from Quebec's Ministère de l'économie, de l'innovation et de l'énergie...
06 October, 2023
/ 0 Comments
NexPlasmaGen receives financial support from the Québec Ministry of Economy, Innovation and Energy, and the Québec Breast Cancer Foundation
Montreal / April 21, 2023 - NexPlasmaGen announces that it has received $511,186 in funding from the ministère de l'économie, de l'innovation et...
21 April, 2023
/ 0 Comments
02 Feb 2023 NexPlasmaGen to present to the OBIO Investment Summit
NEXPLASMAGEN TO PRESENT AT THE 2023 OBIO INVESTMENT SUMMIT Canada’s Premier Health Science Investment Event! Montreal/February 2, 2022 – NexPlasmaGen is proud to announce that...
02 February, 2023
/ 0 Comments
NEXPLASMAGEN is finalist for an ADRIQ innovation award
Montreal / July 4, 2022 NexPlasmaGen is a finalist for the ADRIQ Innovation Award 2022 in the category Innovation from Public Research. The Innovation...
04 July, 2022
/ 0 Comments
NexPlasmaGen to present at the MedInvest Oncology Investor Conference
Montreal/June 23, 2022 – NexPlasmaGen is honored to present at the MedInvest Oncology Investor Conference. The MedInvest Oncology Investor Conference will be hosted in...
23 June, 2022
/ 0 Comments
NexPlasmaGen to present at the 2022 OBIO investment summit
NEXPLASMAGEN TO PRESENT AT THE 2022 OBIO INVESTMENT SUMMIT Canada’s Premier Health Science Investment Event! Montreal/January 30, 2022 – NexPlasmaGen is proud to announce that...
30 January, 2022
/ 0 Comments
NexPlasmaGen’s to present at the Seed showcase 2022
NEXPLASMAGEN TO PRESENT AT SEED SHOWCASE 2022 NexPlasmaGen will pitch its business opportunity to investors! Montreal/December 24 – NexPlasmaGen, today announced that it is presenting...
24 December, 2021
/ 0 Comments